| dc.contributor.author | Morton, D.J. | |
| dc.date.accessioned | 2016-09-27T12:48:59Z | |
| dc.date.available | 2016-09-27T12:48:59Z | |
| dc.date.issued | 1986-01 | |
| dc.identifier.citation | Morton, D. J. (1986). Comparison of In vitro bioavailability of proprietary propranolol preparations. Central African Journal of Medicine, 32 (1), 23-24. | en_US |
| dc.identifier.issn | 0008-9176 | |
| dc.identifier.uri | http://hdl.handle.net/10646/2813 | |
| dc.description.abstract | Dissolution rate studies were conducted to compare the release rate of propranolol from two proprietary preparations. Propranolol was released at a faster rate from Rexigen* when compared to Inderal* which suggests that plasma levels of the drug would be higher in patients taking the former preparation. Both preparations showed satisfactory dissolution but problems may be encountered if a patient stabilized on one brand were to change to the other. | en_US |
| dc.language.iso | en_ZW | en_US |
| dc.publisher | University of Zimbabwe, College of Health Sciences | en_US |
| dc.subject | Propranolol | en_US |
| dc.subject | hypertension | en_US |
| dc.subject | cardiac arrhythmias | en_US |
| dc.title | Comparison of In Vitro bioavailability of proprietary propranolol preparations | en_US |
| dc.type | Article | en_US |
